Morishita Jintan Co., Ltd.
Stock Price Chart
2026/07/15 UpdatedPrice Trend
2026/07/15 UpdatedPrice & Trading Details
2026/07/15 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/06/05Dividend History 4Years Growth
Updated 2026/07/12| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥65 | +18.2% |
| 2025 | ¥55 | +10.0% |
| 2024 | ¥50 | +25.0% |
| 2023 | ¥40 | +6.7% |
| 2022 | ¥38 | - |
Financial Performance
2026/07/12 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥11,359M | ¥12,406M | ¥12,766M | ¥12,688M |
| Gross Profit | ¥5,311M | ¥5,997M | ¥5,973M | ¥6,094M |
| Operating Income | ¥574M | ¥720M | ¥809M | ¥697M |
| Pretax Income | ¥625M | ¥822M | ¥780M | ¥795M |
| Net Income | ¥491M | ¥697M | ¥547M | ¥628M |
| EPS | ¥120.55 | ¥170.68 | ¥133.78 | ¥153.53 |
| Operating Margin | 5.05% | 5.80% | 6.34% | 5.49% |
| Balance Sheet | ||||
| Total Assets | ¥16,103M | ¥17,183M | ¥17,896M | ¥18,623M |
| Total Equity | ¥11,391M | ¥12,143M | ¥12,152M | ¥12,976M |
| Total Liabilities | ¥4,712M | ¥5,040M | ¥5,744M | ¥5,647M |
| Cash | ¥2,409M | ¥1,092M | ¥1,940M | ¥1,828M |
| Interest-bearing Debt | ¥537M | ¥425M | ¥1,457M | ¥1,834M |
| Equity Ratio | 70.74% | 70.67% | 67.90% | 69.68% |
| D/E Ratio | 0.05 | 0.03 | 0.12 | 0.14 |
| Cash Flow | ||||
| Operating CF | ¥1,179M | ¥196M | ¥669M | ¥1,150M |
| Investing CF | -¥474M | -¥1,152M | -¥701M | -¥1,232M |
| Financing CF | -¥433M | -¥362M | ¥880M | -¥30M |
| Free CF | ¥715M | -¥455M | -¥10M | -¥77M |
| Efficiency | ||||
| ROE | 4.31% | 5.74% | 4.50% | 4.84% |
| ROA | 3.05% | 4.06% | 3.06% | 3.37% |
Latest IR Information
-
Notice Regarding the Disposal of Treasury Shares as Restricted Stock Compensation
Read more -
Matters Concerning Controlling Shareholders, etc.
Read more -
Partial Revision of the Basic Policy on the Establishment of Internal Control Systems
Revised the basic policy of the internal control system. Aims to strengthen governance across the group by enhancing the independence of the Audit Committee and Internal Audit Office, expanding the whistleblowing system, and improving the reliability of financial reporting.
Read more
Latest News (5 items)
Company Information
About
Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In addition, the company offers OEM contract services. Further, it develops Jintan capsule technology that allows encapsulating various contents, such as powder, liquid, microbe or others. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Chuo, Japan.
